Nov 5 (Reuters) - Arch Biopartners Inc ARCH.V :
* ARCH BIOPARTNERS ANNOUNCES DOSING OF FIRST PATIENT IN TURKEY IN PHASE II TRIAL OF LSALT PEPTIDE TO TREAT COMPLICATIONS FROM COVID-19
* ARCH BIOPARTNERS INC - EXPLORING OPPORTUNITY TO ADD CANADIAN CLINICAL SITES TO TRIAL
* ARCH BIOPARTNERS INC - PHASE II TRIAL CONTINUES TO RECRUIT PATIENTS IN TWO HOSPITAL SITES IN U.S.